1.Steroid-resistant nephrotic syndrome and CD2AP gene
International Journal of Pediatrics 2011;38(5):512-515
Mutations in CD2AP, mapped to 6pL2. 3 and encoding CD2 - associated protein ( CD2AP), are responsible for autosomal recessive or autosomal dominant steroid - resistant nephrotic syndrome (SRNS). CD2AP plays a key role in the slitdiaphragm network of the kidney, which is necessary for the structure and ultrafiltration functions of the slitdiaphragm. The CD2AP homozygous mutation results in early - onset SRNS while heterozygous expression of the CD2AP mutation has increased susceptibility to glomerular injury.No recurrence of proteinuria was observed in the patient with SRNS with CD2AP homozygousmutationafter the renal transplantation. Therefore, detection of the CD2AP gene in the patients suffering from SRNS will be beneficial to making therapeutic decisions and predicting prognoses.
2.Mutational analysis of NPHS1 gene in children with sporadic steroid-resistant nephrotic syndrome in Southern Chinese Han ethnic group
Daojing WANG ; Zihua YU ; Dachuan MENG ; Rong FU ; Jingjing WANG ; Dongning FENG ; Yonghui YANG
Chinese Journal of Nephrology 2012;28(2):95-100
Objective To elucidate the mutations of NPHS1 gene in children with sporadic steroid-resistant nephrotic syndrome (SRNS) in Southern Chinese Han ethnic group.Methods Peripheral blood samples were collected for genetic analysis from 40 patients with sporadic SRNS and 50 healthy volunteers as control.Genomic DNA was isolated from peripheral blood leucocytes.Twenty-nine exons and exon-intron boundaries of the NPHS1 gene were amplified by polymerase chain reaction.Mutational analysis was performed by DNA sequencing directly.Results Seven variants,928G>A(D310N),2677A>G (T893A),2869G>C (V957L),IVS8+30C>T,IVS21+14G>A,IVS25-23C>T and *142T>C,of NPHS1 gene were found in 6 of 40 children with sporadic SRNS,whereas they were not found in 50 healthy controls.2677A >G,IVS8 +30C >T,IVS21 +14G>A,IVS25-23C >T and *142T>C were novel.Moreover,thirteen already reported NPHS1 polymorphisms,294C>T,349G>A,IVS3+15C>T,IVS3+61A>G,803G>A,IVS8+68A>G,1339G >A,1802G >C,2223C >T,2289C >T,IVS24 +36C >T,3315G>A and IVS27 +45C >T,were detected in some patients and controls. Conclusions NPHS1 mutations in 6 of 40 children with sporadic SRNS in Southern Chinese Han ethnic group (15%) are detected.NPHS1 mutations are existed in Southern Chinese children,so it is necessary to perform the mutation analysis of NPHS1 gene in those children patients.
3.Influencing factors for hierarchical medical system:interpretative structural modeling
Dexin MENG ; Shu′e ZHANG ; Chao FAN ; Yifu RU ; Haiyan LI ; Yu SHI ; Fengzhe XIE ; Libin YANG ; Mohan CHI ; Dachuan MAO ; Tao SUN
Chinese Journal of Hospital Administration 2016;32(7):481-484
Objective To build a multi‐level hierarchical structure model of the influencing factors for hierarchical medical system ,to identify the role relationship between all the factors and transmission pathways ,and to recommend on developing China′s hierarchical medical system . Methods Thirty influencing factors were identified in a screening based on literature review for the hierarchical medical system .On such basis ,16 influencing factors were identified by three health policy experts ,which affect operations of the current system .Interpretative structural modeling was called into play in the end to analyze the hierarchy relationship between various influencing factors and the conduction loops .Results There exist among the 16 factors a 3‐level hierarchical structureand two conduction loops .The factor directly limiting the hierarchical medical system is two‐way referral,and most internal core drivers arehuman resources development and governance mechanism.By means of self‐growth and external constraints ,they exert their influence on the operation of hierarchical medical system .Conclusions There are interactive hierarchical effects among the factors ,merging into three node elements of functional role,inter‐entity relationshipand patient participation.
4.Retrospect and prospect of clinical pathway management in China
Feng ZHU ; Dachuan LI ; Wenbao ZHANG ; Meng ZHANG ; Ying WANG ; Yan XU ; Haixiao CHEN
Chinese Journal of Hospital Administration 2018;34(4):284-287
The main work and achievements of clinical pathway work in China since 2009 were systematically reviewed in the paper. It analyzed the problems existing in the implementation of clinical pathway management in China, and suggested on such management in the future. The suggestions include:deeper understanding, convergence with the payment system reform, strengthened quality control, further informatization,and better performance appraisal system.